Abivax Sa · EURONEXT:ABVX
Sofinnova Crossover I SLP reported a 11.00% stake in Abivax Sa (Schedule 13D/A)
Event Feb 14, 2025 · Filed Feb 14, 2025
Sofinnova Crossover I SLP reported a 11.00% stake in Abivax Sa, 7,794,478 shares, with active intent on Feb 14, 2025. Filed Feb 14, 2025 (Schedule 13D/A).
- Stake
- 11.00%
- Shares
- 7,794,478
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sofinnova Crossover I SLP | 11.00% | 7,794,478 |
| Sofinnova Partners SAS | 11.00% | 7,794,478 |
| Antoine Papiernik | 11.00% | 7,794,478 |
| Cedric Moreau | 11.00% | 7,794,478 |
| Kinam Hong | 11.00% | 7,794,478 |
| Joseph Anderson | 11.00% | 7,794,478 |
| Jacques Theurillat | 11.00% | 7,794,478 |
Source
Related
- Abivax Sa
- Sofinnova Crossover I SLP
- Abivax Sa shareholders
- Schedule 13D/A · Sofinnova Crossover I SLP · Jul 6, 2026
- Schedule 13D/A · Sofinnova Crossover I SLP · May 11, 2026
- Schedule 13D/A · Sofinnova Crossover I SLP · Jan 14, 2026
- Schedule 13D/A · Sofinnova Crossover I SLP · Oct 30, 2025
- Schedule 13D/A · Sofinnova Crossover I SLP · Jul 31, 2025
- AMF threshold crossing notice · The Goldman Sachs Group, Inc. · Oct 16, 2026
- AMF threshold crossing notice · The Goldman Sachs Group, Inc. · Oct 15, 2026
- AMF threshold crossing notice · Bank of America Corporation · Oct 15, 2026
- AMF directors' dealing declaration · Marc De Garidel · Oct 14, 2026
- AMF directors' dealing declaration · Marc De Garidel · Oct 13, 2026